Trial Outcomes & Findings for Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD) (NCT NCT03879044)
NCT ID: NCT03879044
Last Updated: 2021-10-25
Results Overview
Objective measure of sleepiness. Scale ranges between each individual, with the reciprocal of the reaction time being reported.
TERMINATED
NA
30 participants
3 minutes
2021-10-25
Participant Flow
Participant milestones
| Measure |
Transcranial Direct Current Stimulation
Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.
|
|---|---|
|
Overall Study
STARTED
|
30
|
|
Overall Study
COMPLETED
|
26
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
We analyzed data of participants who fully complete baseline questionnaires
Baseline characteristics by cohort
| Measure |
Transcranial Direct Current Stimulation
n=26 Participants
Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.
|
|---|---|
|
Age, Continuous
|
31.33 years
STANDARD_DEVIATION 7.08 • n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Sex: Female, Male
Female
|
24 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Sex: Female, Male
Male
|
2 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
24 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
Black or African American
|
4 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
White
|
18 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
|
Region of Enrollment
United States
|
26 Participants
n=5 Participants • We analyzed data of participants who fully complete baseline questionnaires
|
PRIMARY outcome
Timeframe: 3 minutesPopulation: Objective sleepiness based on Psychomotor Vigilance Test could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.
Objective measure of sleepiness. Scale ranges between each individual, with the reciprocal of the reaction time being reported.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 5 minutesPopulation: Subjective sleepiness based on Karolinska Sleepiness Scale instrument could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.
Subjective measure of sleepiness. Scale ranges from 1-9, with total score being reported.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 5 minutesPopulation: Subjective sleepiness based on Epworth Sleepiness Scale instrument could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.
Subjective measure of sleepiness. The scale ranges from 0-24, with the total score being reported.
Outcome measures
Outcome data not reported
Adverse Events
Transcranial Direct Current Stimulation
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Ulysses Magalang
The Ohio State University Wexner Medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place